We build the software and instrumentation that turn faint, hard-to-read signals — a patient's glucose curve, a coil sweeping over a titanium implant — into decisions people can act on before small problems become serious ones.
One method, two domains
Whether the source is a person or a printed part, Ayaru applies the same discipline: capture the real signal, compare it against what's expected, and act on the difference while it's still small.
Continuous, structured data — glucose readings and questionnaires, or a coil's response as it passes over a titanium surface.
Software reads each signal against a known baseline, surfacing the deviations that actually matter and filtering out the noise.
Caregivers and patients get an earlier, clearer picture. Manufacturers get a defect flagged before an implant ever reaches theatre.
Ayaru runs two activities, each serving a different part of the medtech chain — from living with a chronic disease to trusting the implant that treats one.
A digital platform connecting patients and caregivers around the daily management of chronic disease, starting with type 1 diabetes. Configurable questionnaires, an online course, and a companion app turn scattered self-management into structured, shareable data.
Explore patient education → Activity 02 Industrial inspectionEddy-current inspection built for additively manufactured titanium prostheses — a non-destructive way to catch porosity and subsurface defects that visual checks and calipers simply cannot see, before a part is released.
Explore quality control →Ayaru Sàrl is based in Geneva, Switzerland, and grew out of research collaborations with the University of Geneva. That academic starting point still shapes how we work today: define what a trustworthy signal looks like, build the tools to capture it in the real world — a home, a hospital, a printing floor — and give the people who depend on it a result they can act on with confidence.
info@ayaru.ch · Ayaru Sàrl, 1205 Geneva, Switzerland